News Releases

Corporate Office

VANCOUVER, B.C. CANADA

Facility Location

SOUTHEAST QUEENSLAND AUSTRALIA

Facility Size

51 HECTARES/125 ACRES

Projected Capacity

537,500 KG/ANNUM

Download as PDF  

Asterion to Hold 2019 Annual General Meeting and Corporate Presentations

Vancouver, British Columbia:  Asterion Cannabis Inc.(P.ASTR) (“Asterion” or the “Company”) announces that the Company’s 2019 Annual General Meeting of Shareholders will be held at the Fairmont Vancouver Hotel in the Saturna Room, 900 West Georgia Street, Vancouver, BC, Canada on Thursday, June 20, 2019 at 12:00 p.m. 

Asterion is also pleased to announce that it will be hosting two corporate events involving presentations from Asterion’s senior management, details of which are set out below.  Presenters at the events are expected to include Mr. Stephen Van Deventer, Chairman and CEO, Mr. Paget Hargreaves, President and Director, Mr. Hamish Sutherland, Chief Operating Officer and Mr. Stewart McGlashan, Director of Project Development.

Due to limited space, please pre-register for the events to secure your spot.

Toronto Corporate Presentation Event Details

Date: Tuesday, June 18th, 2019
Time: 1:00 pm - 4:00 pm
Presentation: 1:30 pm - 2:30 pm
Location: Fairmont Royal York
Tudor Room 7 and 8 
100 Front St W, Toronto, Ontario
MC: Stephen Van Deventer

Toronto - Confirm your attendance, register by clicking here: Toronto Eventbrite Link

Vancouver Corporate Presentation Event Details

Date: Thursday, June 20th, 2019
Time 1:00 pm - 4:00 pm 
Presentation: 1:30 - 2:30
Location: Fairmont Vancouver Hotel
Saturna Room
900 West Georgia Street, Vancouver, British Columbia
MC: Stephen Van Deventer

Vancouver - Confirm your attendance, register by clicking here: Vancouver Eventbrite Link

About Asterion

Asterion is a Canadian medicinal cannabis company with operations in Australia, specializing in medical cannabis and is focused on becoming an industry leader in next-generation cannabis products. The Company is focused on the future of precision agriculture and aims to produce the highest quality of genetically uniform cannabis strains, at an affordable price. 

The Company is led by a team of highly experienced executives with over 120 years of combined experience in medical cannabis, renewable energy, capital markets, and other highly relevant sectors across North America, Oceania, Europe, Africa and Asia.

On Behalf of the Board of Directors

“Stephen Van Deventer”
Chairman & Chief Executive Officer

For further information, please contact:

Deanna Kress
+1-778-999-6063
[email protected]

Forward-Looking Statements:

This news release contains forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian and U.S. securities legislation, including the United States Private Securities Litigation Reform Act of 1995.  Other than statements of historical fact, all statements included in this news release, including, without limitation, statements regarding the Company’s anticipated business plans and prospects of success in executing its plans, are forward-looking statements that involve various risks and uncertainties.  There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements.  Various risks and uncertainties could cause actual results to differ materially from Asterion’s expectations.  Other factors such as general economic, market or business conditions, future prices of cannabis, changes in the financial markets and in the demand and market price for cannabis, or changes in laws, regulations and policies affecting the biotechnology or cannabis industry, and delays in obtaining governmental and regulatory approvals, may also adversely affect the future results or performance of the Company.  Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. 

 

November 12, 2019

Asterion Lodges Operational Works Permit Application for Development at its Medicinal Cannabis Propagation and Pro [...]

arrowRead More
November 6, 2019

Asterion Receives Development Approval Permit for its Medicinal Cannabis Propagation and Processing Facility

arrowRead More
August 26, 2019

Asterion Announces Appointment of Mr. Peter Ryan as Director of Development (Australia)

arrowRead More

arrowView All News

Stay up to date with our latest news:

What are you searching for?

Stay up to date with our latest news:

Sign up to receive updates
Are you of legal age in your province or territory of residence?